Filing Details
- Accession Number:
- 0001209191-16-117771
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-05 16:12:41
- Reporting Period:
- 2016-05-03
- Filing Date:
- 2016-05-05
- Accepted Time:
- 2016-05-05 16:12:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214496 | S Christian Schade | 311 C Enterprise Dr Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-03 | 7,829 | $41.21 | 18,550 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-03 | 7,829 | $70.42 | 10,721 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-05-03 | 7,829 | $0.00 | 7,829 | $41.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-08-19 | No | 4 | M | Direct |
Footnotes
- Includes 358 shares of common stock issued as restricted stock pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $70.30 to $70.57.
- 25% of the stock options vest every quarter from the grant date of 8/19/2008.
- This option was previously reported as covering 7,500 shares at an exercise price of $47.63 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.